Search research articles
Contact Us
Filters
Showing results (181-190 of 305) with videos related to
Page
of 31
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
May 10, 2011
Validation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86-72-51
Thomas B Daniels, Paul D Brown, Sara J Felten, et al.
Cancer Research
|
September 24, 2009
MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes
Yunqing Li, Fadila Guessous, Ying Zhang, et al.
Neuroradiology
|
August 11, 2022
MRI features predict tumor grade in isocitrate dehydrogenase (IDH)-mutant astrocytoma and oligodendroglioma
David A Joyner, John Garrett, Prem P Batchala, et al.
Neuro-Oncology
|
February 8, 2011
A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma
Patrick Y Wen, David Schiff, Timothy F Cloughesy, et al.
Journal of Neuro-Oncology
|
December 12, 2024
Primary diffuse leptomeningeal glioblastoma: a case report and literature review
Mark Willy L Mondia, Rebekka E Hooks, Georgios A Maragkos, et al.
Neuro-Oncology
|
February 13, 2019
Recent developments and future directions in adult lower-grade gliomas: Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) consensus
David Schiff, Martin Van den Bent, Michael A Vogelbaum, et al.
Radiology
|
November 13, 2019
MRI and CT Identify Isocitrate Dehydrogenase <i>(IDH)</i>-Mutant Lower-Grade Gliomas Misclassified to 1p/19q Codeletion Status with Fluorescence in Situ Hybridization
Sohil H Patel, Prem P Batchala, E Kelly S Mrachek, et al.
Journal of Neuro-Oncology
|
January 24, 2024
Phase I study targeting newly diagnosed grade 4 astrocytoma with bispecific antibody armed T cells (EGFR BATs) in combination with radiation and temozolomide
Camilo E Fadul, Archana Thakur, Jungeun Kim, et al.
Neuro-Oncology
|
October 11, 2017
Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients naive to antiangiogenic therapy
Patrick Y Wen, Jan Drappatz, John de Groot, et al.
Journal of Neuro-Oncology
|
August 11, 2019
Tumor pharmacokinetics and pharmacodynamics of the CDK4/6 inhibitor ribociclib in patients with recurrent glioblastoma
Todd W Miller, Nicole A Traphagen, Jing Li, et al.
Page
of 31
Search research articles
Search
Showing results (181-190 of 305) with videos related to
Sort By:
Page
of 31
International Journal of Radiation Oncology, Biology, Physics
|
May 10, 2011
Validation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86-72-51
Thomas B Daniels, Paul D Brown, Sara J Felten, et al.
Cancer Research
|
September 24, 2009
MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes
Yunqing Li, Fadila Guessous, Ying Zhang, et al.
Neuroradiology
|
August 11, 2022
MRI features predict tumor grade in isocitrate dehydrogenase (IDH)-mutant astrocytoma and oligodendroglioma
David A Joyner, John Garrett, Prem P Batchala, et al.
Neuro-Oncology
|
February 8, 2011
A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma
Patrick Y Wen, David Schiff, Timothy F Cloughesy, et al.
Journal of Neuro-Oncology
|
December 12, 2024
Primary diffuse leptomeningeal glioblastoma: a case report and literature review
Mark Willy L Mondia, Rebekka E Hooks, Georgios A Maragkos, et al.
Neuro-Oncology
|
February 13, 2019
Recent developments and future directions in adult lower-grade gliomas: Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) consensus
David Schiff, Martin Van den Bent, Michael A Vogelbaum, et al.
Radiology
|
November 13, 2019
MRI and CT Identify Isocitrate Dehydrogenase <i>(IDH)</i>-Mutant Lower-Grade Gliomas Misclassified to 1p/19q Codeletion Status with Fluorescence in Situ Hybridization
Sohil H Patel, Prem P Batchala, E Kelly S Mrachek, et al.
Journal of Neuro-Oncology
|
January 24, 2024
Phase I study targeting newly diagnosed grade 4 astrocytoma with bispecific antibody armed T cells (EGFR BATs) in combination with radiation and temozolomide
Camilo E Fadul, Archana Thakur, Jungeun Kim, et al.
Neuro-Oncology
|
October 11, 2017
Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients naive to antiangiogenic therapy
Patrick Y Wen, Jan Drappatz, John de Groot, et al.
Journal of Neuro-Oncology
|
August 11, 2019
Tumor pharmacokinetics and pharmacodynamics of the CDK4/6 inhibitor ribociclib in patients with recurrent glioblastoma
Todd W Miller, Nicole A Traphagen, Jing Li, et al.
Page
of 31